Updates on the Role of Adrenal Steroidogenesis Inhibitors in Cushing’s Syndrome: A Focus on Novel Therapies

Pituitary- Netherlands

doi 10.1007/s11102-016-0742-1

Full Text

Abstract

Available in

Categories

Date

September 6, 2016

Authors

Frederic Castinetti

Publisher

Springer Science and Business Media LLC

Related search

Review: Updates on Novel Therapies for Metastatic Renal Cell Carcinoma

Therapeutic Advances in Medical Oncology

English

The Diversity of Abnormal Hormone Receptors in Adrenal Cushing's Syndrome Allows Novel Pharmacological Therapies

Brazilian Journal of Medical and Biological Research

English

New Targeted Therapies in Myelodysplastic Syndrome: The Role of Farnesyltransferase and Proteasome Inhibitors

BMC Proceedings

Molecular Biology

English

Studies on the Metabolism of Trilostane,an Inhibitor of Adrenal Steroidogenesis.

Chemical and Pharmaceutical Bulletin

English

A Case Report and Review on Cushing’s Syndrome

Indian Journal of Pharmacy Practice

English

Adrenal Suppression and Cushing’s Syndrome Secondary to Ritonavir and Budesonide

South African Medical Journal

English

Effect of Nitric Oxide on Rat Adrenal Zona Fasciculata Steroidogenesis

Journal of Endocrinology

English

Updates on Advanced Therapies for Acute Pulmonary Embolism

International Journal of Cardiovascular Practice

English

New Diagnostic Criteria of Adrenal Subclinical Cushing’s Syndrome: Opinion From the Japan Endocrine Society

Endocrine Journal

English